Literature DB >> 17636872

Redox reactions of copper complexes formed with different beta-amyloid peptides and their neuropathological [correction of neuropathalogical] relevance.

Dianlu Jiang1, Lijie Men, Jianxiu Wang, Yi Zhang, Sara Chickenyen, Yinsheng Wang, Feimeng Zhou.   

Abstract

The binding stoichiometry between Cu(II) and the full-length beta-amyloid Abeta(1-42) and the oxidation state of copper in the resultant complex were determined by electrospray ionization-Fourier transform ion cyclotron resonance mass spectrometry (ESI-FTICR-MS) and cyclic voltammetry. The same approach was extended to the copper complexes of Abeta(1-16) and Abeta(1-28). A stoichiometric ratio of 1:1 was directly observed, and the oxidation state of copper was deduced to be 2+ for all of the complexes, and residues tyrosine-10 and methionine-35 are not oxidized in the Abeta(1-42)-Cu(II) complex. The stoichiometric ratio remains the same in the presence of more than a 10-fold excess of Cu(II). Redox potentials of the sole tyrosine residue and the Cu(II) center were determined to be ca. 0.75 and 0.08 V vs Ag/AgCl [or 0.95 and 0.28 V vs normal hydrogen electrode (NHE)], respectively. More importantly, for the first time, the Abeta-Cu(I) complex has been generated electrochemically and was found to catalyze the reduction of oxygen to produce hydrogen peroxide. The voltammetric behaviors of the three Abeta segments suggest that diffusion of oxygen to the metal center can be affected by the length and hydrophobicity of the Abeta peptide. The determination and assignment of the redox potentials clarify some misconceptions in the redox reactions involving Abeta and provide new insight into the possible roles of redox metal ions in the Alzheimer's disease (AD) pathogenesis. In cellular environments, the reduction potential of the Abeta-Cu(II) complex is sufficiently high to react with antioxidants (e.g., ascorbic acid) and cellular redox buffers (e.g., glutathione), and the Abeta-Cu(I) complex produced could subsequently reduce oxygen to form hydrogen peroxide via a catalytic cycle. Using voltammetry, the Abeta-Cu(II) complex formed in solution was found to be readily reduced by ascorbic acid. Hydrogen peroxide produced, in addition to its role in damaging DNA, protein, and lipid molecules, can also be involved in the further consumption of antioxidants, causing their depletion in neurons and eventually damaging the neuronal defense system. Another possibility is that Abeta-Cu(II) could react with species involved in the cascade of electron transfer events of mitochondria and might potentially sidetrack the electron transfer processes in the respiratory chain, leading to mitochondrial dysfunction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17636872      PMCID: PMC3222686          DOI: 10.1021/bi700508n

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  82 in total

1.  Mitochondrial DNA damage as a mechanism of cell loss in Alzheimer's disease.

Authors:  S M de la Monte; T Luong; T R Neely; D Robinson; J R Wands
Journal:  Lab Invest       Date:  2000-08       Impact factor: 5.662

2.  Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease.

Authors:  Suzanne M de la Monte; Jack R Wands
Journal:  J Alzheimers Dis       Date:  2006-07       Impact factor: 4.472

Review 3.  The key role of mitochondria in Alzheimer's disease.

Authors:  P I Moreira; S M Cardoso; M S Santos; C R Oliveira
Journal:  J Alzheimers Dis       Date:  2006-07       Impact factor: 4.472

4.  Copper-dependent inhibition of cytochrome c oxidase by Abeta(1-42) requires reduced methionine at residue 35 of the Abeta peptide.

Authors:  Peter J Crouch; Kevin J Barnham; James A Duce; Rachel E Blake; Colin L Masters; Ian A Trounce
Journal:  J Neurochem       Date:  2006-10       Impact factor: 5.372

5.  Metal binding modes of Alzheimer's amyloid beta-peptide in insoluble aggregates and soluble complexes.

Authors:  T Miura; K Suzuki; N Kohata; H Takeuchi
Journal:  Biochemistry       Date:  2000-06-13       Impact factor: 3.162

6.  Copper(II) binding modes in the prion octapeptide PHGGGWGQ: a spectroscopic and voltammetric study.

Authors:  R P Bonomo; G Imperllizzeri; G Pappalardo; E Rizzarelli; G Tabbì
Journal:  Chemistry       Date:  2000-11-17       Impact factor: 5.236

7.  Binding of Zn(II), Cu(II), and Fe(II) ions to Alzheimer's A beta peptide studied by fluorescence.

Authors:  W Garzon-Rodriguez; A K Yatsimirsky; C G Glabe
Journal:  Bioorg Med Chem Lett       Date:  1999-08-02       Impact factor: 2.823

8.  Dioxygen binds end-on to mononuclear copper in a precatalytic enzyme complex.

Authors:  Sean T Prigge; Betty A Eipper; Richard E Mains; L Mario Amzel
Journal:  Science       Date:  2004-05-07       Impact factor: 47.728

9.  Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/beta protein.

Authors:  M F Knauer; B Soreghan; D Burdick; J Kosmoski; C G Glabe
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

10.  Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2).

Authors:  Carlos Opazo; Xudong Huang; Robert A Cherny; Robert D Moir; Alex E Roher; Anthony R White; Roberto Cappai; Colin L Masters; Rudolph E Tanzi; Nibaldo C Inestrosa; Ashley I Bush
Journal:  J Biol Chem       Date:  2002-08-20       Impact factor: 5.157

View more
  46 in total

1.  Regenerable and simultaneous surface plasmon resonance detection of aβ(1-40) and aβ(1-42) peptides in cerebrospinal fluids with signal amplification by streptavidin conjugated to an N-terminus-specific antibody.

Authors:  Ning Xia; Lin Liu; Michael G Harrington; Jianxiu Wang; Feimeng Zhou
Journal:  Anal Chem       Date:  2010-11-12       Impact factor: 6.986

2.  A kinetic model for beta-amyloid adsorption at the air/solution interface and its implication to the beta-amyloid aggregation process.

Authors:  Dianlu Jiang; Kim Lien Dinh; Travis C Ruthenburg; Yi Zhang; Lei Su; Donald P Land; Feimeng Zhou
Journal:  J Phys Chem B       Date:  2009-03-12       Impact factor: 2.991

3.  Structural studies of copper(I) complexes of amyloid-beta peptide fragments: formation of two-coordinate bis(histidine) complexes.

Authors:  Richard A Himes; Ga Young Park; Gnana Sutha Siluvai; Ninian J Blackburn; Kenneth D Karlin
Journal:  Angew Chem Int Ed Engl       Date:  2008       Impact factor: 15.336

Review 4.  Environmental and Dietary Exposure to Copper and Its Cellular Mechanisms Linking to Alzheimer's Disease.

Authors:  Heng-Wei Hsu; Stephen C Bondy; Masashi Kitazawa
Journal:  Toxicol Sci       Date:  2018-06-01       Impact factor: 4.849

5.  The Rich Electrochemistry and Redox Reactions of the Copper Sites in the Cellular Prion Protein.

Authors:  Feimeng Zhou; Glenn L Millhauser
Journal:  Coord Chem Rev       Date:  2012-05-04       Impact factor: 22.315

6.  Kinetic studies of inhibition of the amyloid beta (1-42) aggregation using a ferrocene-tagged β-sheet breaker peptide.

Authors:  Lin Zhang; Gargey Yagnik; Yong Peng; Jianxiu Wang; H Howard Xu; Yuanqiang Hao; You-Nian Liu; Feimeng Zhou
Journal:  Anal Biochem       Date:  2012-12-08       Impact factor: 3.365

7.  The elevated copper binding strength of amyloid-β aggregates allows the sequestration of copper from albumin: a pathway to accumulation of copper in senile plaques.

Authors:  Dianlu Jiang; Lin Zhang; Gian Paola G Grant; Christopher G Dudzik; Shu Chen; Sveti Patel; Yuanqiang Hao; Glenn L Millhauser; Feimeng Zhou
Journal:  Biochemistry       Date:  2013-01-11       Impact factor: 3.162

8.  Aggregation pathways of the amyloid β(1-42) peptide depend on its colloidal stability and ordered β-sheet stacking.

Authors:  Dianlu Jiang; Iris Rauda; Shubo Han; Shu Chen; Feimeng Zhou
Journal:  Langmuir       Date:  2012-08-22       Impact factor: 3.882

9.  Binding of alpha-synuclein with Fe(III) and with Fe(II) and biological implications of the resultant complexes.

Authors:  Yong Peng; Chengshan Wang; Howard H Xu; You-Nian Liu; Feimeng Zhou
Journal:  J Inorg Biochem       Date:  2009-11-18       Impact factor: 4.155

10.  Ternary complexes of iron, amyloid-beta, and nitrilotriacetic acid: binding affinities, redox properties, and relevance to iron-induced oxidative stress in Alzheimer's disease.

Authors:  Dianlu Jiang; Xiangjun Li; Renee Williams; Sveti Patel; Lijie Men; Yinsheng Wang; Feimeng Zhou
Journal:  Biochemistry       Date:  2009-08-25       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.